Docosahexaenoic Acid News and Research

RSS

Docosahexaenoic acid or DHA is an omega-3 essential fatty acid. DHA is the most abundant essential fatty acid (polyunsaturated fatty acids, PUFAs) in the brain and retina.

Vitamin D, omega-3 fatty acids may optimize brain serotonin concentrations and function

Although essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the context of certain brain disorders, the underlying mechanism has been unclear. In a new paper published in FASEB Journal by Rhonda Patrick, PhD and Bruce Ames, PhD of Children's Hospital Oakland Research Institute, serotonin is explained as the possible missing link tying together why vitamin D and marine omega-3 fatty acids might ameliorate the symptoms associated with a broad array of brain disorders.

27 Feb 2015

Omega-3 could supplement anti-VEGF treatment in AMD

Pilot study findings suggest that taking omega-3 fatty acid supplements could increase the efficacy or reduce the needed frequency of anti-vascular endothelial growth factor treatment in patients with exudative age-related macular degeneration.

13 Feb 2015

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered gene interactions that determine whether cells live or die in such conditions as age-related macular degeneration and ischemic stroke.

31 Jan 2015

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy.

28 Jan 2015

Walnuts may improve cognitive function

Eating walnuts may improve performance on cognitive function tests, including those for memory, concentration and information processing speed according to new research from the David Geffen School of Medicine at The University of California, Los Angeles, led by Dr. Lenore Arab. Cognitive function was consistently greater in adult participants that consumed walnuts, regardless of age, gender or ethnicity.

21 Jan 2015

Pivotal Therapeutics announces accomplishments, financial results for Q3 2014

Pivotal Therapeutics Inc., ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its accomplishments and financial results for the three months ended September 30, 2014.

29 Nov 2014

Omega-3 fatty acids decrease risk of getting heart disease

Increasing the amount of omega-3s in your diet, whether from fish or flax, will likely decrease your risk of getting heart disease, according to Penn State nutritionists.

18 Nov 2014

Omega-3 fish oil may protect against alcohol-related neurodamage

Omega-3 fish oil might help protect against alcohol-related neurodamage and the risk of eventual dementia, according to a study published in the journal PLOS ONE.

18 Jul 2014

Pivotal Therapeutics reports reduced revenue in first quarter 2014

Pivotal Therapeutics Inc., ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2014.

31 May 2014

U.S. adults not meeting DGA recommended levels for omega-3 fatty acid consumption

A study published in the Nutrition Journal concludes that a large percent of the U.S. adult population is not meeting recommendations for omega-3 fatty acid consumption set for by the Dietary Guidelines for Americans.

16 May 2014

Prenatal DHA supplementation does not improve cognitive outcomes in children

Although there are recommendations for pregnant women to increase their intake of the omega-3 fatty acid docosahexaenoic acid (DHA) to improve fetal brain development, a randomized trial finds that prenatal DHA supplementation did not result in improved cognitive, problem-solving or language abilities for children at four years of age, according to the study in the May 7 issue of JAMA, a theme issue on child health.

5 May 2014

Alcresta signs agreement with CFFT to support nutritional status of people with cystic fibrosis

Alcresta, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the company has signed an agreement with Cystic Fibrosis Foundation Therapeutics (CFFT) to accelerate the development of Alcresta's enzyme-based point-of-care products to support the nutritional status of people with cystic fibrosis (CF).

17 Apr 2014

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.

19 Mar 2014

Study: Daily dietary supplements not associated with reduced risk for CVD in elderly

Daily dietary supplements of omega-3 polyunsaturated fatty acids (also found in fish) or lutein and zeaxanthin (nutrients found in green leafy vegetables) were not associated with reduced risk for cardiovascular disease (CVD) in elderly patients with the eye disease age-related macular degeneration.

19 Mar 2014

Study provides evidence for importance of omega-3 fatty acids in healthy brain development

Monkeys that ate a diet rich in omega-3 fatty acids had brains with highly connected and well organized neural networks - in some ways akin to the neural networks in healthy humans - while monkeys that ate a diet deficient in the fatty acids had much more limited brain networking, according to an Oregon Health & Science University study.

5 Feb 2014

Early onset of dietary treatment may slow down progression of Alzheimer's disease

New research findings indicate that an early onset of dietary treatment may slow down the progression of Alzheimer's disease. The study was conducted on mice, and the results will be published in the February issue of Journal of Nutritional Biochemistry. Researchers from the University of Eastern Finland played a key role in the study, which was carried out as part of the LiPiDiDiet project funded by the European Union.

24 Jan 2014

Docosahexaenoic Acid News and Research

Vitamin D, omega-3 fatty acids may optimize brain serotonin concentrations and function

Omega-3 could supplement anti-VEGF treatment in AMD

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Walnuts may improve cognitive function

Pivotal Therapeutics announces accomplishments, financial results for Q3 2014

Omega-3 fatty acids decrease risk of getting heart disease

Omega-3 fish oil may protect against alcohol-related neurodamage

Pivotal Therapeutics reports reduced revenue in first quarter 2014

U.S. adults not meeting DGA recommended levels for omega-3 fatty acid consumption

Prenatal DHA supplementation does not improve cognitive outcomes in children

Alcresta signs agreement with CFFT to support nutritional status of people with cystic fibrosis

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

Study: Daily dietary supplements not associated with reduced risk for CVD in elderly

Study provides evidence for importance of omega-3 fatty acids in healthy brain development

Early onset of dietary treatment may slow down progression of Alzheimer's disease

Early onset of dietary treatment may slow down progression of Alzheimer's, says research

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

Research: Omega-3 fatty acids in dietary supplements can cross blood brain barrier in Alzheimer's patients

Pivotal Therapeutics reports financial results for Q3 2013

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News